Skip to main content
. 2024 Sep 13;16:11795735241260563. doi: 10.1177/11795735241260563

Figure 3.

Figure 3.

Time to discontinuation of each index therapy in the NTD-matched cohorts for time to first relapse outcome over 288 weeks. DMF, dimethyl fumarate; FTY, fingolimod; GA, glatiramer acetate; IFN β-1a, interferon β-1a; NTD, NeuroTransData registry; NTZ, natalizumab; TERI, teriflunomide.